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ABSTRACT 
Reptin is a member of the AAA+ superfamily whose members can exist in 
equilibrium between monomeric apo forms and ligand bound hexamers. Inter-subunit 
protein-protein interfaces that stabilize Reptin in its oligomeric state are not well-
defined. A self-peptide binding assay identified a protein-peptide interface mapping to 
an inter-subunit “rim” of the hexamer bridged by Tyrosine-340. A Y340A mutation 
reduced ADP-dependent oligomer formation using a gel filtration assay, suggesting 
that Y340 forms a dominant oligomer stabilizing side chain. The monomeric 
ReptinY340A mutant protein exhibited increased activity to its partner protein AGR2 in 
an ELISA assay, further suggesting that hexamer formation can preclude certain 
protein interactions. Hydrogen-deuterium exchange mass spectrometry (HDX-MS) 
demonstrated that the Y340A mutation attenuated deuterium suppression of Reptin in 
this motif in the presence of ligand. By contrast, the tyrosine motif of Reptin interacts 
with a shallower pocket in the hetero-oligomeric structure containing Pontin and 
HDX-MS revealed no obvious role of the Y340 side chain in stabilizing the Reptin-
Pontin oligomer. Molecular dynamic simulations (MDS) rationalized how the Y340A 
mutation impacts upon a normally stabilizing inter-subunit amino acid contact.  MDS 
also revealed how the D299N mutation can, by contrast, remove oligomer de-
stabilizing contacts. These data suggest that the Reptin interactome can be regulated 
by a ligand dependent equilibrium between monomeric and hexameric forms through 
a hydrophobic inter-subunit protein-protein interaction motif bridged by Tyrosine-
340. 
                                                 
1
 joint first authors. 
2
 joint corresponding authors. 
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Significance 
Discovering dynamic protein-protein interactions is a fundamental aim of research in 
the life sciences. An emerging view of protein-protein interactions in higher 
eukaryotes is that they are driven by small linear polypeptide sequences; the linear 
motif.  We report on the use of linear-peptide motif screens to discover a relatively 
high affinity peptide-protein interaction for the AAA+ and pro-oncogenic protein 
Reptin. This peptide interaction site was shown to form a ‘hot-spot’ protein-protein 
interaction site, and validated to be important for ligand- induced oligomerization of 
the Reptin protein.  These biochemical data provide a foundation to understand how 
single point mutations in Reptin can impact on its oligomerization and protein-protein 
interaction landscape.  
 
INTRODUCTION  
The AAA+ superfamily contains a group of ATP-regulated hexameric proteins that 
are highly conserved in evolution [1]. Their dynamic oligomeric properties provide a 
model system to understand allosteric regulation of polypeptide assembly and 
function [2].  The RuvBl1/2 orthologues, also named Reptin and Pontin, represent two 
representative AAA+ protein members.  Structural studies have defined the properties 
of complexes of homo-oligomeric Pontin [3], hetero-dodecameric Pontin and Reptin 
[4] and homo-hexameric Reptin [5]. There are two ATP-binding motifs in such 
AAA+ proteins: the Walker A and Walker B ATP-binding motifs that mediate ATP 
binding and hydrolysis respectively. 
 
Reptin’s key evolutionarily conserved activity, from yeast to vertebrates, regulates 
chromatin-modifying machinery, including Ino80 [6, 7], and SCRAP [8]. Additional 
protein-protein interactions from studies in human cancer include those with ATF2 
[9], Myc [10], transcription associated protein β-catenin [11], tumor suppressor ARF 
[12], and the oncogenic protein AGR2 [13]. Reptin and Pontin are also regulators of 
all PIKK (phosphatidylinositol 3-kinase-related protein kinase) members [14] that in 
turn mediate the DNA damage response and nonsense-mediated mRNA decay 
(NMD). Reptin and Pontin also regulate the assembly of the telomerase holoenzyme 
through interactions with TERT and dyskerin [15]. A major paradigm in Reptin 
structure and function was identified using yeast models where it forms a multi-
subunit chaperonin complex with HSP90 [16].  
 
Reptin is a potential drug target in cancer due to its oncogenic nature and large ATP-
binding pocket that might make it suitable for drug-discovery programmes [17]. As 
such, we had previously performed in silico screening of a large chemical library to 
identify several lead molecules that can interact with the Walker A ATP-binding site 
[18].  The screen resulted in the small molecule Liddean which: (i) mimicked ATP or 
ADP in the stimulation of the oligomerization of Reptin protein; (ii) regulated 
Reptin’s heterologous protein-protein interactions; and (iii) stimulated Reptin 
assembly with Pontin in cell-based systems. Together these observations suggested 
that occupation of the ATP-pocket of Reptin by a small molecule ATP-mimetic like 
Liddean can stimulate its oligomerization.  In this report, we focus on understanding 
the role of ligand binding in promoting key protein-protein contacts at the 
oligomerization interface of Reptin during its self-oligomerization. We identified an 
inter-subunit hotspot in the ‘rim’ of the hexamer at Tyrosine-340 that plays an 
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important role in ligand- induced oligomerization that promotes hexamer stability and 
regulates Reptin’s specific activity.  
 
EXPERIMENTAL PROCEDURES  
 
Site Directed Mutagenesis of Reptin at D299N and at Y340A 
All chemicals were obtained from Sigma unless otherwise indicated. Human Reptin 
was cloned into Gateway Entry clone (Invitrogen) for subsequent use. The human 
Reptin sequence for cloning into a new E. coli expression system was amplified using 
the following primers: forward primer 5′-GGGACAAGTTTGTACAA 
AAAAGCAGGCTTCCTGGAAGTTCTGTTCCAGGGGCCC 
ATGGCAACCGTTACAGCCACAACC-3′ and reverse primer 
5′-
GGGGACCACTTTGTACAAGAAAGCTGGGTCCAGGAGGTGTCCATGGTCTC
G-3′. The forward primer had a PreScission protease cleavage site inserted. Following 
amplification, the polymerase chain reaction (PCR) product was first inserted into 
pDONR201 and then into pDEST-15 using Gateway technology (Invitrogen) to 
generate GST-tagged Reptin. Point mutations in the above mentioned plasmids were 
introduced using the following primers: for the Reptin D299N mutant, forward primer 
5′-GAGTGCTGTTCATCAACGAGGTCCACATGC-3′ and reverse primer 5′-
GCATGTGGACCTCGTTGATGAACAGCACTC-3′; and for the Reptin Y340A 
mutant, forward 5’- GAATCCGGGGCACCAGCGCCCAGAGCCCTCACGGCA-3’ 
and reverse  5’- GCCGTGAGGGCTCTGGGCGCTGGTGCCCCGGATTC-3”. 
 
Expression and Purification of Proteins.  
a. Reptin WT and Mutant production. Reptin proteins were expressed as 
indicated previously [13]. Briefly, plasmids encoding the indicated Reptin 
proteins were transformed into BL21-AI (Thermo Fischer Scientific). The cells 
were grown in LB medium (1 L) at 37°C up to an A600 of 0.5. Induction of gene 
expression was achieved by adding arabinose to the culture (final concentration 
0.2%). The bacterial culture was grown at room temperature (21oC) for another 
3 hours and then pelleted by centrifugation.  The lower temperature of induction 
(rather than 30oC or 37oC) gave rise to reproducible recover of Reptin protein. 
Cells were lysed with 30 ml of a buffer containing 10% sucrose, 50 mM HEPES, 
pH 8.0, 400 mM NaCl, 0.1% Triton X-100, 1 mM DTT, 1 mM benzamidine, 0.5 
mg/ml lysozyme, and protease inhibitors for 30 min on ice and then sonicated 
for 3 x 5 second bursts to reduce the viscosity. The clarified bacterial lysate was 
obtained by centrifugation for 15 min at 15,000 g.  The lysate was incubated with 
glutathione beads (0.5 ml) (GE Healthcare) for 150 min at 4°C with rotation in a 
50 ml conical tube. The beads were thoroughly washed three times by mixing the 
beads with 10 bead-volumes of a high salt buffer (20 mM HEPES, pH 7.5, 1 M 
NaCl, 1 mM DTT, and 1 mM benzamidine) to remove non-specifically bound 
proteins. The beads were then washed three times with 10 bead-volumes of a 
low salt buffer (20 mM HEPES, pH 7.5, 0.05 M NaCl, 1 mM DTT, and 1 mM 
benzamidine). The beads were finally washed three times with 10 bead-volumes 
of PreScission buffer (GE Healthcare, Uppsala, Sweden) and then resuspended in 
1 bead volume (0.5 ml) of PreScission buffer. GST-tagged PreScission protease 
(GE Healthcare; 5 units) was added to the slurry and incubated overnight 
rotating in the cold room.  The beads were sedimented at 2,340 g for one minute 
and the supernatant containing cleaved Reptin protein was recovered. The 
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purity of Reptin was confirmed using SDS-gel electrophoresis as described 
previously [13]. The beads were washed with an additional column volume of 
PreScission buffer to collect additional, but more diluted protein. The first 
fraction from the elution, which is more concentrated than the second fraction, 
was invariably used. The Reptin protein cleaved off the column using PreScission 
protease (GE Healthcare) was stored at 4°C at concentrations from 0.5 mg/ml to 
1 mg/ml. The protein was stable in this condition for at least 6 months.   
b. AGR2 Purification. His-tagged AGR2 (from [19]) was expressed in BL21-AI and 
purified using Ni2+-nitrilotriacetic acid-agarose (Qiagen) 
according to the manufacturer's instructions. In detail, the cells were grown in 
LB medium (0.5 L) at 37 °C up to an A600 of 1.0 and protein was induced by 
adding arabinose to the culture (0.2%). The culture was grown at 30oC for 3 
hours and then pelleted by centrifugation.  The pellets were lysed with 40 ml of a 
buffer containing 20 mM Tris–HCl, pH 8.0, 150 mM NaCl, 10 mM MgCl2, 0.05% 
Tween 20, 10% glycerol, 20 mM imidazole, pH 8.0, and 0.5 mg/ml lysozyme for 
30 minutes on ice. The lysate was then sonicated for 3 x 5 second bursts to 
reduce the viscosity. The clarified bacterial lysate was obtained by centrifugation 
for 15 minutes at 15,000 g. The lysate was incubated with Ni-agarose on rotary 
shaker at 4°C for 1 hour to capture the AGR2 protein.  The beads were washed 
two times in lysis buffer and three times in lysis buffer with 40 mM imidazole, 
and then the AGR2 protein was eluted with lysis buffer containing 150 mM 
imidazole. Purity was confirmed using SDS-gel electrophoresis as described [19].  
AGR2 protein eluted from the column was stored at -70°C at concentrations from 
1-3 mg/ml. The protein was stable in this condition for at least 2 years.   
c. HSP90 purification. The coding sequence of the human HSP90AA1 gene 
(Hsp90α, NM_001017963.2) was cloned into a pDEST17 vector containing an N-
terminal His 6x-tag cleavable by TEV protease. All cloned genes were expressed 
in BL21(DE3) RIPL cells. The cells were grown in LB medium at 37°C up to an A600 
of 0.5. Induction of gene expression was achieved by adding isopropyl β -D-
thiogalactopyranoside to the culture (final concentration 1 mM). The bacterial 
culture was grown at 30°C for another 3–4 hours and then pelleted by 
centrifugation for 15 minutes at 6,000 g. The cells were resuspended in His 
binding buffer II (50 mM Tris, pH 8.0, 0.2 M NaCl, 2 mM MgCl2, 10% glycerol). 
Cell suspensions were enriched with lysozyme (1 mg/ml) and PMSF (1 mM) and 
then sonicated. Bacterial lysates were obtained by centrifugation for 30 minutes 
at 12,000 g. His 6 -tagged Hsp90α was purified using a HisTrap column, and the 
His 6 x-tag was cleaved by overnight incubation with TEV protease. The protein 
was subsequently exchanged into His binding buffer II and then subjected to a 
second immobilized metal affinity chromatograph to remove His 6 x-tag and His 
6-TEV. The flow-through fractions were concentrated and further processed by 
gel filtration using a HiPrep 16/60 Sephacryl S-200 HR column (GE Healthcare). 
The purity of all isolated proteins was confirmed by SDS-PAGE/Coomassie 
staining [20]. All proteins were finally exchanged into final assay buffers using 7-
kDa molecular mass cutoff Zeba spin desalting column (Thermo Fischer). 
 
Reptin ELISA protein-peptide Interaction Assays. Overlapping biotinylated peptides 
were obtained from Chiron Mimotopes (Australia). Peptides derived from Reptin are 
displayed in the Figure 1 legend. Reptin protein binding to biotinylated protein was 
measured using ELISA. Fifteen-mer peptides with a 5-mer overlap (Figure 1A) and 
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containing a N-terminal biotin followed by a SGSG spacer were purchased from 
Chiron Mimotopes. Peptides were dissolved at 5 mg/ml in DMSO. In peptide binding 
assays, ELISA plates were coated with streptavidin (AnaSpec) overnight at 37oC and 
washed with PBS-Tween-20 (0.1% Tween-20). The biotinylated peptides diluted in 
water (1 g per well) were added for 1 hour followed by blocking with BSA 3% in 
PBS 1X.  Reptin diluted in blocking buffer was then added to the plate and incubated 
for a further 1 hour. When ligands such as ADP or Liddean were used, the chemicals 
were added to buffer containing Reptin for 30 minutes prior to addition of the 
reactions to the ELISA wells to allow sufficient oligomerization of the protein 
induced by the ligands. Blocking buffer and DMSO only controls were included. 
After further washes, wells were incubated with the Reptin primary antibody and then 
horseradish peroxidase conjugated secondary antibody for 1 hour each at room 
temperature followed by further washing and ECL addition and the luminescence 
produced was measured.  The data are presented as Relative Light Units and represent 
triplicates graphed as a mean with error bars representing the deviations from the 
mean.  
 
Gel Filtration. Reptin and the indicated mutants (Y340A and D299N; 25 g) were 
incubated without ligand or with ligand (1 mM ADP) in 100 l of HEPES buffer (pH 
7.6) containing PBS. Samples were injected onto a 25 ml Superose-12 gel filtration 
column in the same buffer and fractions were collected at a flow rate of 0.5 
ml/minute. In the ligand bound state, the column was pre-incubated in the same buffer 
but including 1 mM ADP.  Gel filtration markers were used to calibrate the column 
and to demonstrate ADP did not alter the elution of marker proteins (data not shown). 
Samples eluting from the column (50 l) of each fraction were absorbed onto ELISA 
wells overnight in a cold room and wells were incubated with PBS with BSA (3%) to 
block reactive interaction sites. The wells were washed with PBS-tween-20 (0.1%) 
followed by incubation with the anti-Reptin antibody (1:1000; Abcam) in PBS-tween-
20 (0.1%) including BSA (3%). Reactions were processed with HRP-conjugated 
secondary antibodies (DAKO; 1:1000) to define the elution profile of Reptin (in RLU, 
chemiluminescence).  The elution profiles are highlighted in Figure 3. Molecular 
mass markers (GE Healthcare) that calibrated the column were injected  (100 l) at 10 
mg/ml concentrations (in deionized water) and elution peak volumes were defined by 
absorbance (max280 nm).  
 
Experimental Design and Statistical Rationale for Hydrogen-deuterium Exchange 
Mass Spectrometry.  
a. Sample Preparation of Reptin Proteins - Reptin, either wt or mutant (5 M), was 
incubated with 1 mM ATP for 1 hour at 21°C prior to the exchange. The exchange 
was initiated by a sequential dilution into deuterated buffer (50 mM Tris-HCl pD 7.1, 
150 mM NaCl, 1 mM EDTA, 2 mM MgCl2 and 1 mM DTT) to a final concentration 
of 2 µM. The sequential dilution took approximately 25 seconds. Counting of the 
incubation time was initiated after addition of the first aliquot of deuterated buffer. 
For sample with ATP the deuterated buffer was enriched with 1 mM ATP.  The 
exchange was carried out at room temperature and was quenched by the addition of 1 
M HCl in 1 M glycine at 5 minutes followed by rapid freezing in liquid nitrogen.  
b. Digestion and HPLC Separation. Each sample was thawed and injected onto an 
immobilized pepsin column (15 µl bed volume, flow rate 20 µl/minute, 2% 
acetonitrile/0.05% trifluoroacetic acid). Peptides were trapped and desalted on- line on 
a peptide microtrap (Michrom Bioresources, Auburn, CA) for 2 minutes at flow rate 
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20 µl/minute. Next, the peptides were eluted onto an analytical column (Jupiter C18, 
1.0 x 50 mm, 5 µm, 300Å, Phenomenex, CA) and separated using a 2 minute linear 
gradient elution of 10%-40% B buffer in A buffer, followed by 31 minute isocratic 
elution at 40% B. Solvents used were: A buffer – 0.1% formic acid in water, B buffer 
– 80% acetonitrile/0.08% formic acid. The immobilized pepsin column, trap cartridge 
and the analytical column were kept at 1°C.  
c. Mass Spectrometry and Data Analysis. Mass spectrometric analysis was carried out 
using an Orbitrap Elite mass spectrometer (Thermo Fisher Scientific) with ESI 
ionization on- line connected with a robotic system based on the HTS-XT platform 
(CTC Analytics, Zwingen, Switzerland).  The instrument was operated in a data-
dependent mode for peptide mapping (HPLC-MS/MS). Each MS scan was followed 
by MS/MS scans of the top three most intensive ions from both CID and HCD 
fragmentation spectra. Tandem mass spectra were searched using SequestHT against 
the cRap protein database (ftp://ftp.thegpm.org/fasta/cRAP) containing the sequence 
of the Reptin protein with the following search settings: mass tolerance for precursor 
ions of 10 ppm, mass tolerance for fragment ions of 0.6 Da, no enzyme specificity, 
two maximum missed cleavage sites and no-fixed or variable modifications were 
applied. The false discovery rate at peptide identification level was set to 1%. 
Sequence coverage was analysed with Proteome Discoverer software version 1.4 
(Thermo Fisher Scientific) and graphically visualized with MS Tools application [21]. 
Totally 94% of Reptin sequence was covered by 249 identified peptides 
(Supplementary Figure 1). Analysis of deuterated samples was done in HPLC-MS 
mode with ion detection in the orbital ion trap. The MS raw files together with the list 
of peptides (peptide pool) identified with high confidence characterized by requested 
parameters (retention time, XCorr, and charge) were processed using HDExaminer 
version 2.2 (Sierra Analytics, Modesto, CA).  The software analyzed protein and 
peptides behavior, created the uptake plots that showed peptide deuteration over time 
with calculated confidence level (high, medium confidence are accepted, low 
confidence is rejected). The HDX data in Figures 5 and 7 are representative of data 
obtained in at least three independent experiments. The results from peptide pools 
(Supplementary Tables 1-3) were displayed as butterfly comparison plots 
(Supplementary Figures 2-4) that showed the deuteration percentage as a function of 
peptide index calculated for different protein states. This function includes other 
useful information about how well the peptide pool covers protein (number of 
peptides, percentage of coverage protein sequence, standard deviation, average 
redundancy etc., Supplementary Figs. S2-S4). Other graphs showing the evolution of 
deuteration at individual parts of the protein at the same time and different protein 
states were plotted using the GraphPad Prism version 5.03 for Windows (GraphPad 
Software, San Diego, CA, USA). The bimodal isotopic envelopes were analyzed by 
HX-Express 2 [22]. Molecular structures were rendered using PyMOL [23]. The mass 
spectrometry proteomics data have been deposited to the ProteomeXchange 
Consortium via the PRIDE repository with the dataset identifier “PXD008226”; 
Username: reviewer05996@ebi.ac.uk, Password: I7pjGxG1. 
 
Modelling and Molecular Dynamics (MD) Simulations.  
MD simulations of apo and ADP bound monomeric and hexameric Reptin in its wt, 
Y340A and D299N mutant forms were carried out with the pemed.CUDA module of 
the program Amber14 [24]. The structures of the mutants (Y340A, D299N) were 
generated by substituting Tyr340 with Ala and Asp299 with Asn in the wild-type 
protein [5]. All atom versions of the Amber 14SB force field (ff14SB) [25] and the 
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generalized Amber force field (GAFF) [26] were used to represent the protein and 
ADP respectively. The Xleap module was used to prepare the system for the MD 
simulations. Each structure was solvated in an octahedral box with TIP3P [27] water 
molecules, leaving at least 10 Å between the solute atoms and the borders of the box. 
All the simulation systems were neutralized with appropriate numbers of counterions. 
MD simulations were carried out in explicit solvent at 300K. During the simulations, 
the long-range electrostatic interactions were treated with the particle mesh Ewald 
[28] method using a real space cutoff distance of 9 Å. The Settle [29] algorithm was 
used to constrain bond vibrations involving hydrogen atoms, which allowed a time 
step of 2 fseconds during the simulations. Solvent molecules and counterions were 
initially relaxed using energy minimization with restraints on the protein and inhibitor 
atoms. This was followed by unrestrained energy minimization to remove any steric 
clashes. Subsequently the system was gradually heated from 0 to 300 K using MD 
simulations with positional restraints (force constant: 50 kcal mol-1 Å-2) on protein 
and inhibitors over a period of 0.25 nseconds allowing water molecules and ions to 
move freely. During an additional 0.25 nseconds, the positional restraints were 
gradually reduced followed by a 2 nseconds unrestrained MD simulation to 
equilibrate all the atoms. For each system, three independent MD simulations 
(assigning different initial velocities) were carried out for 250 nseconds with 
conformations saved every 10 pseconds. Figures were drawn using PyMOL [23]. 
 
 
 
 RESULTS  
 
Defining hotspot Reptin interaction sites using an overlapping biotinylated Reptin 
self-peptide library array.  
Reptin forms multiple inter-subunit protein-protein interaction contacts. However, the 
dominating, functional interaction sites or “hot-spots” that stabilize inter-subunit 
protein-protein interactions [30] involved in Reptin homo-oligomer assembly are not 
well-defined. The emerging view of protein interactions in higher eukaryotes 
highlights the concept that the large portion of protein-protein interactions are driven 
by linear peptide motifs that encompass hotspots for stabilizing domain-domain 
interactions [31]. We used this concept as an approach to determine whether Reptin 
exhibits self-binding activity towards linear peptide motifs derived from the Reptin 
amino acid sequence. We set up an overlapping biotinylated peptide scan assay using 
sequences derived from Reptin (Figure 1A) to identify self-peptides that might 
interact stably with the protein. Identification of such linear peptides could point out 
high affinity, functional, “hotspots” in inter-subunit protein-protein docking site. 
 
Synthetic biotinylated peptides contained a SGSG amino acid spacer followed by the 
appropriate overlapping Reptin amino acid sequence are listed in Figure 1A. The 
biotinylated peptides were captured on streptavidin coated ELISA wells and unbound 
peptides was washed away. Monomeric Reptin was added to measure binding 
activity. There was only one major, dominating self-peptide binding activity that was 
mapped to peptide 28 (Figure 1A; Biotin-SGSG-GITRIRGTSYQSPHG) which 
resides at an inter-subunit region of the Reptin oligomer (Figure 1B). This peptide 
forms a tyrosine finger which embeds into each adjacent subunit in the hexameric 
structure (Figure 1C). We name this tyrosine-containing peptide a click motif. 
Interestingly, deuterium exchange mass spectrometry was used previously to 
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demonstrate that the Reptin ligand and ADP-mimetic named Liddean suppressed 
deuteration at this site within the ring structure formed between all six subunits [18]. 
These data are consistent with a model that oligomerization induced by Liddean 
might suppress deuteration at this buried inter-subunit interface motif.  
 
Ligands that induce Reptin oligomerization suppress its interaction with the click 
interface peptide 28 
We next set up assays that measure the impact of a ligand that can induce Reptin 
oligomerization on its binding to peptide 28. A titration of Reptin protein (up to 320 
ng) into ELISA wells coated with either peptide 27, peptide 28, or peptide 29 (Figure 
1A) confirmed that the protein exhibits a high preference for peptide 28 (Figure 2A). 
This peptide contains the amino acid sequence with the bridging Tyrosine 340 amino 
acid side chain (Figure 1C).  Using this assay, we next determined whether Reptin 
binding to peptide 28 can be affected by ligands that induce its oligomerization. Using 
fixed amount of Reptin (500 ng), increasing concentrations of ADP from 1 M to 200 
M resulted in a reduction in its binding to peptide 28 (Figure 2B). Similarly, 
increasing the concentrations of Liddean from 1 M to 200 M resulted in 
suppression of Reptin binding to peptide 28 (Figure 2B).  As a control, the weak 
binding activity of Reptin observed to peptide 27 was also reduced by increasing the 
concentrations of either ADP or Liddean (Figure 2B). These data are consistent with 
the hypothesis that Reptin homo-oligomer formation stabilized through the inter-
subunit docking of the peptide 28 click motif to the adjacent subunit (as in Figure 1B 
and 1C) would sterically preclude the self-peptide 28 binding in trans.   
 
We next also evaluated previously identified Reptin interacting proteins, as controls, 
to determine how ligand- induced oligomerization impacts on Reptin binding activity. 
Liddean was used as an ATP mimetic ligand that binds to the Walker-A ATP binding 
domain [18]. ADP was also used to eliminate the contribution of ATPase activity of 
Reptin from the Walker B ATP-interaction site to its dynamic oligomerization.  
AGR2 is a previously published Reptin binding protein whose binding to Reptin has 
been fine-mapped [18].  As expected, we observed that both Liddean and ADP 
reduced Reptin binding to AGR2 (Figure 2C).  
 
Reptin is part of the R2TP complex and can interact with certain molecular 
chaperones, including HSP90 [32]. A titration of Reptin alone resulted in relatively 
low levels of binding to the HSP90 chaperone (Figure 2C). The pre-incubation of 
Reptin with either Liddean or ADP (500 M) increased the binding activity of Reptin 
(Figure 2D). Liddean was more potent than ADP in stimulating the HSP90-Reptin 
complex (Figure 2D). This is consistent with the increased potency of Liddean to 
induce SDS-stable oligomerization of Reptin [18]. These data suggest that the ligand 
bound form of Reptin (presumably oligomeric) or the ligand-free form of Reptin 
(presumably monomeric) have different affinities for partner proteins (summarised in 
Figure 4).  
 
Mutation of tyrosine-340 within the click peptide motif reduces ligand-stimulated 
oligomerization of Reptin.  
These data can be used to predict that if we mutate the Y340-peptide oligomerization 
interface (Figure 1C) we might alter Reptin oligomerization. In addition, we might 
also impact on the affinity of Reptin for these proteins whose binding is regulated by 
Reptin oligomerization states (as in Figure 2).  In order to determine whether the 
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Y340A mutation can impact on Reptin oligomerization states, we evaluated the 
relative mass of the wild-type and mutant Reptin by quantifying their elution profiles 
using gel filtration.  
 
Two mutant forms of Reptin were purified and characterized compared to the wild-
type protein. We chose to mutate Tyrosine 340 to Alanine (ReptinY340A), since the 
Tyrosine side-chain forms a possible key hydrophobic stabilizing interaction between 
monomers (Figure 1C). We then asked how the loss of this apparently stabilizing 
tyrosine amino acid contact (Figure 1C) can impact on ligand-dependent 
oligomerization. We also chose to mutate Aspartate 299 to Asparagine (ReptinD299N). 
This mutation resides within the Walker B ATP binding domain and is implicated as a 
gain-of- function inhibitor of Reptin in cell growth since it has enhanced ATP-binding 
activity [13] because of a defective ATPase activity [33].  However, to our 
knowledge, despite significant functional cell based data on the biochemical 
characteristics of this D299N mutant, there has been no analysis of its oligomerization 
status in the absence and presence of ligand.  As such, we included this mutant as 
another control to evaluate how the oligomerization of Reptin might be affected in 
comparison to the Y340A mutation.  
 
An ELISA assay was used to measure the elution of Reptin from a Superose-12 gel 
filtration column and then to define its relative oligomerization state in the ligand-free 
and ligand bound forms. Following elution from the gel filtration column, aliquots of 
the fractions were absorbed onto 250 l ELISA wells. Protein was detected using 
immunochemical detection as indicated in the Experimental Procedures. We would 
predict at the outset that wt-Reptin would exhibit an increase in its oligomerization 
status in the presence of ligand. We would predict that the ReptinY340A mutant would 
presumably be less oligomeric if our hypothesis is accurate that the Y340 side chain 
forms a stabilizing hotspot interaction with the adjacent subunit. We did not know at 
the outset how the ReptinD299N mutant would elute in the absence and presence of 
ligand.  
 
We processed the samples without ADP or with ADP in the gel filtration buffer (1 
mM), rather than ATP, as the use of ADP removes the contribution of ATP hydrolysis 
to the dynamic oligomerization state of the protein over the course of the gel filtration 
elution (90 minutes).  Relative to molecular mass markers, wt-Reptin elutes as an 
apparent monomer on S12-sepharose (Figure 3A). The preincubation of Reptin with 
ADP, and including ADP in the gel filtration buffer, results in an increase in a pool of 
the protein at a larger mass range suggesting the elution of a stable oligomer (a 
hexamer based on crystal structure data).  We found that a reproducible proportion of 
the Reptin did not shift into the fully oligomeric (presumably hexameric) position, as 
highlighted by the presence of two peaks in the gel filtration elution profile (Figure 
3A).  These data suggest there might be two distinct conformational pools of the 
recombinant Reptin purified from bacterial host (as suggested by bimodal hydrogen 
deuterium exchange data, see below). Alternatively, the gel filtration methodologies 
might dilute Reptin during the chromatography, reducing its concentration 
sufficiently below its association constant in the presence of ligand.  
 
Elution of ReptinY340A protein resulted in a protein that mimicked wt-Reptin profile in 
the absence of ligand but the inclusion of ADP in the buffer did not result in a shift it 
into a larger oligomeric state (Figure 3B). These data suggest that the Y340 does 
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provide a hotspot stabilization interaction between the subunits as its mutation 
precludes stable oligomer formation in the presence of the ligand.  This is consistent 
with the ability of peptide-28 (containing the tyrosine 340 residue) to bind with a 
relatively high affinity to Reptin (Figure 1A). As the unknown control, to our 
surprise, the ATP-binding gain-of- function mutant ReptinD299N resulted in a profile (in 
the absence of ligand) that mimics wt-Reptin bound to ADP (Figure 3C). These latter 
data suggest that the D299N mutant traps Reptin in an oligomeric state without 
ligand.  These data are rationalized using molecular dynamic simulations (below) and 
we include this D299N mutant in our discussion on oligomer fluctuation as a 
comparison to the Y340A and wt forms of Reptin (Figure 4).  The data also suggest, 
although the D299N mutation has been defined as ‘inactive’ in cells due to its low 
ATPase activity, with respect to oligomerization, the D299N mutation induces a 
‘gain-of- function’ property to the protein. However, since the protein is ATP 
hydrolysis inactive, it would presumably be not only gain-of- function with respect to 
oligomerization but dominant negative in its activity in cells.  
 
Having established that the panel of wild-type and mutant proteins exhibit different 
oligomerization properties in the presence or absence of ligand, we next tested all in a 
range of biochemical assays to correlate oligomerization potential to its specific 
activity. This panel of Reptin proteins (wt-Reptin, ReptinY340A, ReptinS342A, and 
ReptinD299N) was next tested for binding to one of its most well-characterized binding 
proteins; the oncogenic AGR2 protein [13]. The binding of either wild-type Reptin or 
ReptinS342A to AGR2 are relatively similar (Figure 3D) suggesting that the Serine 342 
site chain does not form a hot spot stabilizing interaction. Interestingly, ReptinD299N 
exhibited a much lower specific activity in this AGR2 binding assay (Figure 3D). 
Since ReptinD299N exhibits enhanced oligomerization without ligand (Figure 3C), 
these data are consistent with the prior data showing that that the ligand-bound form 
of Reptin has reduced AGR2 binding activity (Figure 2D).  By contrast, the 
ReptinY340A exhibited a much higher specific activity that wild-type Reptin in this 
AGR2 binding assay (Figure 3D). These data are also consistent with the concept that 
Reptin can exist in dynamic oligomeric states.  The monomeric state of the Y340A 
mutant (as suggested by Figure 3B) can increase its binding to some proteins such as 
AGR2 (Figure 3D and Figure 4).  
 
Use of Hydrogen-deuterium exchange mass spectrometry (HDX-MS) to measure 
Reptin oligomerization dynamics.  
HDX-MS was used to measure the effect of ATP on the conformation of Reptin and 
the impact of the Y340A mutation on these properties. We have previously used 
HDX-MS methodology to define conformational changes induced upon mutation or 
ligand binding in proteins including MDM2 [34], CHIP [35], EpCAM [36], and 
HSP70 [37]. We first compared deuteration of wt-Reptin with deuteration of wt-
Reptin pre- incubated with 1 mM ATP (Figure 5 and Figure 6A).  Peptic peptide 
segments that exhibited different deuterium exchange rates at 300 seconds post-
dilution with deuterated buffer as result of ATP binding are highlighted in Figure 5 
(in red). The data reflect changes in deuteron number as a function of the indicated 
peptic peptide fragments. These peptides are located in all three Reptin functional 
domains (Figure 6A).   In domain I (Figure 1D and Figure 6A), these segments 
contain amino acids 63-109 that comprise the ATP-binding Walker A motif 
(Supplementary Figure 5A; in white). This is consistent with ATP occupying the 
nucleotide binding pocket of Reptin under these conditions and serves as a positive 
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control that the ATP-binding reaction was active under the deuteration dilution 
conditions.  In addition, domain I containing amino acids 298-318, comprising the 
Walker B motif, also exhibited attenuated deuteration (Supplementary Figure 5A; in 
blue). This is also consistent with ligand interaction at this site leading to suppression 
of deuteration. A third motif in domain I includes amino acids 340-351 (Figure 6A, in 
red) that contains the Tyrosine-340 residue and comprises the so-called “click” motif 
that is proposed to be an important stabilizing amino acid involved in inter-subunit 
stability (Figure 1C). These latter data are consistent with the model that ligand 
binding results in hexamer formation and that this leads to lowered solvent 
accessibility and/or structural fluctuations of the “click” motif containing Tyrosine-
340.   
 
In domain II, also known as the insertion domain, deuterium suppression induced by 
ATP includes segments containing amino acids 179-194 and 275-282 (Figure 6A; and 
(Supplementary Figure 5B; in white). This domain is proposed to bind DNA and/or 
RNA. In domain III, which is also part of the ATP pocket, we were unable to map 
peptides to almost half of the domain using pepsin digestion (see grey regions in 
Figure 6A). However, in the remaining part of domain III, deuteration suppression 
was observed in segments comprising amino acids 355-371 and 412-433 (Figure 6A 
and (Supplementary Figure 5B; in blue)). Other previously dissected functional 
domains of Reptin were also examined. The Arg finger (R353) was not covered by 
peptic peptides. The sensor I region (amino acids M326 - N329) exhibited no changes 
in deuteration and the sensor II region (amino acids T397 - A402) was also not 
covered by peptic peptides.  An inter-subunit protein-protein interface (amino acids 
428-439) were suppressed by ligand (Supplementary Figure 5C; in white). 
 
Next, we compared the deuteration of ReptinY340A and ReptinY340A with 1 mM ATP to 
determine the effects of reduced oligomerization (Figure 3B) using deuteration as an 
assay (Figure 5 and Figure 6B). The presence of ATP induced structural changes in 
ReptinY340A which are similar to that observed with wild-type Reptin (Figures 4 and 6; 
A vs B). Peptic segments that exhibited slower deuterium exchange as a result of ATP 
binding are highlighted in Figure 6B (in red). In contrast to wt-Reptin, there are two 
segments located in domain I and domain II (amino acids 114-123 and amino acids 
275-282 respectively; highlighted in Figure 6B, in blue color) that exhibited increase 
in deuteration after incubation with ATP. These data suggest that this region in 
ReptinY340A becomes more exposed to solvent after ATP binding and is suggestive of 
a lower rate of hexamer formation.  Decreases in deuteration were detected similarly 
as in wt-Reptin in domain I (segments 51-74 and 90-109) and domain III (segments 
355-399 and 411-433).  
 
Interestingly no changes of deuteration were detected in the Y340 peptide docking 
motif (Y340) in the ReptinY340A mutant but decreases in deuteration was observed 
after the amino acid at position 355 (Figure 5B and Figure 6B).  The neutral effects of 
ligand on the deuteration of the Y340 peptide docking motif in ReptinY340A protein are 
consistent with the model that loss of Tyrosine 340 precludes full “hexamerization” of 
the Reptin monomer.  
 
Finally, as a control, we compared the deuteration of the Reptin-Pontin complex and 
Reptin-Pontin complex with 1mM ATP (Figure 5 and Figure 6C). Deuterium 
incorporation was reduced by ATP in two segments of Reptin (Figure 5). Peptides 
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protected by ATP in the HDX-MS analysis are highlighted on the structure of Reptin 
(Fig. 5). The first protected segment with reduced deuteration includes amino acids 
63-109 and comprise the Walker A motif. This result is similar to that for wt Reptin 
and is in accordance with ATP binding to the ATP pocket. The second segment which 
showed reduced deuterium uptake (amino acids 355-433) belongs to domain III. As 
seen for ReptinY340A, the decrease of deuteration caused by ATP was observed in the 
region following the Y340 peptide docking motif. This suggests that the Y340 peptide 
docking motif does not participate in the formation of the Reptin-Pontin complex.  By 
contrast, the Reptin-Pontin complex incubated with ligand, no changes of deuteration 
were detected in domain II (Figure 5).  
 
Bimodal distribution in MS spectra.  
A summary of Reptin oligomer dynamics is reviewed in Figure 4. The oligomer 
dynamics in the presence of ligand can also change as a function of the absolute 
concentration of Reptin. The concentration of Reptin decreases upon dilution with 
D2O. We might predict, therefore, that the HDX methodology can give rise to 
transient, distinct populations of Reptin as the monomer begins to assemble in the 
presence of ligand. When analyzing the HDX-MS data, we observed bimodal 
distributions of several wt-Reptin peptides in samples with ATP that were not present 
in the ReptinY340A mutant.   An illustration of bimodal spectra is in Figure 7. These 
peptides were located in the ATP pocket, specifically around the walker A motif in 
domain I and around the Y340 peptide docking motif in domain III.  Notably, the 
bimodal isotopic envelops occurred only in peptides that exhibited conformational 
changes upon ligand binding. The Reptin-Pontin complex also exhibited bimodal 
distributions in the presence of ligand (Figure 7).  A bimodal distribution could result 
from EX1 HDX kinetics in which the rate of conformational change of the 
corresponding peptide is slower than the HDX rate.  The other possible explanation of 
bimodal distribution is the presence of two different protein isoforms, and here it may 
arise from the distribution of monomeric and oligomeric forms of Reptin. This is 
supported by the fact that no bimodal distribution was detected in ReptinY340A (data 
not shown) and further, that the change in the pattern of deuteration appeared after the 
binding of ATP, which is known to initiate Reptin oligomerization. Moreover, the 
location of peptides with bimodal isotopic patterns also supports this interpretation, 
because the ATP pocket is located in between two Reptin molecules in the Reptin 
oligomer.  
 
A complication of these data interpretation is that HDX-MS provides only an average 
of the deuteration of a given peptide length and does not necessarily provide fine-
resolution mapping of a protein-protein interface. For example, our prior study 
discussed, using AGR2 as a model protein [36],  that higher levels of deuterium 
suppression in a small stretch of the polypeptide are compensated by elevated 
deuteration in adjacent regions (due to conformational changes) so that the net 
deuteration in larger peptides is different than the smaller peptide. Thus, it is possible 
that this methodological limitation impacts on the number of deuterons measured in a 
given peptic fragment (as in Figure 5).  This limitation did not preclude the 
identification of regions whose deuteration can be altered through mutation of Y340. 
In addition, oligomeric proteins present a different problem which might relate to 
bimodal distributions (Figure 7). When Reptin assembles into an oligomer, we do not 
know which monomer a given peptide originates from within the hexamer. A solution 
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to this might be isotopic labelling of a Reptin pool so that upon mixing with normal 
isotopic Reptin, inter-subunit interactions might be revealed in the mixed olgiomer.  
 
 
Use of Molecular Dynamic (MD) Simulations to measure Reptin oligomerization 
dynamics. We carried out MD simulations to probe the above interpretations (Figure 
4). It is evident that the Y340 sidechain remains embedded in the adjacent subunit 
(Figure 8A and 8C; Figure 9C), stabilized by a hydrogen bond with the sidechain of 
Thr333 and also by packing interactions with the sidechains of Arg330 and Arg336 
(all 3 residues belonging to the neighboring chain); this is seen in the MD simulations 
of both wild type Reptin and in the D299N Reptin mutant (Supplementary Movie 1 
and Supplementary Movie 3). In contrast, in the Y340A Reptin mutant (Figure 8B; 
Figure 9D), the sidechain Ala has no polar groups to form the hydrogen bond, 
resulting in the loop containing Y340 moving away by about 5Å.  The buried surface 
areas between the monomers (Figure 9A in the wild type Reptin and the D299N 
mutant) remain similar in their liganded states while the apo form of wild type Reptin 
samples two states – one that resembles the packed liganded states and the other more 
open state which is similar to that sampled by the Y340A mutant which loses key 
interactions that stabilize the hexamer (Supplementary Movie 2).  
 
As a control, D299N Reptin is very stable because the interface near the sidechain of 
D299 is anionic with several negatively charged groups (arising from the sidechains 
of E107, E300 and the phosphate of the ligand in the same chain as D299 and the 
sidechains of D349 and D352 from the neighboring chain, all within 8-9Å of D299). 
The loss of the anionic sidechain of D299 in the D299N mutation results in the 
attenuation of the repulsions; in addition, the N299 sidechain is further stabilized by a 
water mediated interaction with D349 from the neighboring chain (Figure 9A and 
9B). This is also apparent in snapshots from the MD simulations (Supplementary 
Movies 1-3). 
 
DISCUSSION 
 
Reptin forms a model AAA+ superfamily member with which to develop new 
approaches for dissecting stages in ligand-mediated oligomer assembly. In the past 
thirty years, the dominant tools used by proteomics approaches to discovery protein-
interactions have been; (i) the yeast two hybrid; and (ii) immuno-precipitations. It is 
also now known that the vast diversity of protein interaction dynamics in higher 
eukaryotes appear to be regulated by small linear peptide motifs (27). Linear motifs in 
peptides can form ‘hotspots’ that play dominant role in driving protein-protein 
interactions and might form key target for drugging protein-protein interactions [38, 
39]. A classic example is the oncogenic protein MDM2; which can form a high 
affinity interaction with a small synthetic peptide derived from the p53 tumour 
suppressor [40] and which has been the basis for drug that target the linear peptide 
binding pocket of MDM2 [41].  
 
Thus, a methodological approach for identifying hotspot protein-peptide interaction 
sites is using either synthetic peptides or phage-combinatorial peptide libraries [42].  
Overlapping synthetic peptide scan assays using peptides derived from the open 
reading frame of Reptin were used to determine whether self-peptides that interact 
stably with Reptin itself, could be identified. This approach revealed a relatively high 
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affinity, self-assembly interface that stabilizes the Reptin hexamer (dominating by 
Tyrosine 340).  Only one self-binding motif for Reptin was identified (peptide 28; 
Figure 1). For example, peptides derived from the an inter-subunit interface region of 
Reptin (amino acids ~420-440) did not bind Reptin in this assay. This highlights a 
limitation of this assay; it can not necessarily identify any protein-protein contact 
dominated by linear peptide motifs. However, peptides that do bind in such assays 
form compelling models to dissect out mechanisms of linear-peptide-protein docking. 
 
The single dominating self-peptide maps to the Reptin hexameric “rim” (Figure 1B), 
with a Tyrosine residue (Y340) forming an inter-subunit stabilizing anchor (Figures 
8-9).  The subunit that interacts with the tyrosine-containing donor peptide forms a 
small acceptor pocket (Figure 9). Size exclusion chromatography affirmed that 
ligand- induced oligomerization of mutant Y340A Reptin is attenuated (Figure 3B).   
 
There is presumably combinatorial diversity in this Y340 donor-acceptor docking 
reaction.  Although the Y340 side chain forms an important stabilizing contact in a 
Reptin-Reptin homo-oligomer, it might not be as important in a Reptin-Pontin hetero-
oligomer (Figure 6C). Further, whether the ‘rim’ of a Pontin-Pontin oligomer also 
forms a hotspot stabilizing contact in this vicinity requires additional functional 
studies. An unexpected result from our studies, that complements the identification of 
Y340 as an important driver of Reptin assembly, was the impact of the D299N 
mutation on oligomerization.  
 
The D299N version of Reptin, lacks ATPase activity and has classically been used as 
a ‘loss-of- function’ mutant [33].  However, this mutant has an elevated ATP-binding 
activity [13].  In our current study, we can interpret the data that the D299N mutant 
produces a spontaneous oligomer in the absence of ligand (Figure 3C).  Molecular 
Dynamics simulations show that the ability of Y340A Reptin to form stable oligomers 
is attenuated because of the loss of the hydrogen bond and packing afforded by the 
sidechain of Y340 against neighboring monomers (Figure 8-9). However, in the 
D299N Reptin mutant, destabilizing, negatively charged inter-subunit contacts are 
removed, resulting in the stabilization of the hexamer in the absence of ligand (Figure 
9; Movie 3). This gives a more complex interpretation to cell based studies using the 
D299N mutant of Reptin. Its inhibitory effect on growth could be because of (i) 
defects in ATPase function; (ii) elevated ATP-binding; or (iii) elevated spontaneous 
oligomerization (this study). In the latter case, since Reptin’s specific activity in 
protein-binding assays is regulated by its monomer and oligomerization status (Figure 
4), then in cells the ReptinD299N mutant could be inhibitory for cell growth because of 
alterations in its interactome.  
 
In conclusion, our pipeline approach for dissecting ‘hotspot’ interactions in one 
AAA+ family member provides a blueprint to produce functional mutants based 
on self-assembly peptide motif scans.  Our data highlight a novel linear motif in 
Reptin that forms an inter-subunit bridge that appears to play a role in hexamer 
stability. Such mutant forms of Reptin (Y340A) can be used in the future in cell 
systems to dissect the interactome of Reptin as a function of monomer to 
oligomer states (Figure 4).  There is a precedent for the ability of small peptides 
to interact with dynamic forms of Reptin; a recent biochemical study evaluated 
the impact of histones on Reptin and Pontin transcriptional regulation  [43]. The 
authors identified histone-3 peptides that not only regulate the monomer-
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oligomer transition of Reptin and Pontin but showed that endogenous proteins 
immuno precipitated by monomeric Reptin are distinct from proteins that 
interact with oligomers. These data highlight the functional importance of Reptin 
oligomerization in controlling its interactome (as in Figure 4 and [43]). 
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Figure 1.  Structure of Reptin (RUVBL2). (A) ELISA assay measuring the 
binding of wt-Reptin to self-peptides. The bottom right diagram highlights the 
order of addition in the Reptin binding reaction, including; (i) coating the ELISA 
wells with Streptavidin (S); (ii) adding the biotinylated peptide containing a 
SGSG space; (iii) the addition of Reptin protein; and (iv) the addition of the 
primary anti-reptin antibody (Y shape; in grey) that is detected using HRP 
conjugated secondary antibody. The top panel summarized the overlapping, 
biotinylated peptides derived from the Reptin open reading frame (from the N-
terminus (peptide 1) through the C-terminus (peptide 40) were coated onto 
streptavidin ELISA wells. After washing, Reptin was added and binding 
measured using anti-Reptin antibody in conjunction with HRP labeled secondary 
antibody. Reactions were monitored via chemiluminescence. Binding data is 
represented by RLU (relative light units) as a function of peptide number. (B) X-
ray crystal structure of the Reptin hexamer (PDB id: 3UK6) with the subunits 
shown in different colors (red, magenta, blue). An inter-subunit interface (428-
439) is colored green and the oligomerization site (333-345) is colored aqua. (C) 
Details of the oligomerization site (aqua) between two Reptin monomers (blue 
and magenta). The side chain of the Tyrosine finger (Y340) is located in the 
oligomerization pocket of the second Reptin. (D). Reptin structure. A linear rod 
structure of Reptin domain organization. Domain DI (in purple) containing 
highly conserved motifs of AAA+ proteins such as the Walker A, the Walker B, 
the Sensor I, the Arg finger and the “Click” (inter-subunit stabilizing) motif 
described in this article. Domain DIII (in red) contains the conserved motif of 
AAA+ protein region named Sensor II. The insertion domain DIII is also 
highlighted. 
 
Figure 2.  Impact of ligands on the protein-binding function of Reptin. (A). 
ELISA wells pre-coated with streptavidin were incubated with the indicated peptides 
(27, 28, and 29) representing the motif surrounding the self-binding peptide (28; 
Figure 1).  Reptin was titrated to measure relative binding. Anti-Reptin and HRP-
conjugated secondary antibodies were used to measure the extent of Reptin binding 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
(in RLU, chemiluminescence). (B). ELISA wells pre-coated with streptavidin were 
incubated with the indicated peptides (27 and 28). Reptin (500 ng) was preincubated 
with or without increasing concentrations of the indicated ligand (DMSO), Liddean, 
or ADP) in buffer (50 l). Anti-Reptin and HRP-conjugated secondary antibodies 
were used to measure the extent of Reptin binding (in RLU, chemiluminescence). (C). 
The previously published Reptin binding proteins (AGR2) was coated onto ELISA 
wells. Reptin was titrated with or without the indicated ligand (DMSO, ADP (100 
M), or Liddean (100 M)). Anti-Reptin and HRP-conjugated secondary antibodies 
were used to measure the extent of Reptin binding (in RLU, chemiluminescence). (D). 
The previously identified Reptin interacting protein, HSP90, was coated onto ELISA 
wells. Reptin was titrated with or without the indicated ligand (DMSO, ADP (500 
M), or Liddean (500 M)). Anti-Reptin and HRP-conjugated secondary antibodies 
were used to measure the extent of Reptin binding (in RLU, chemiluminescence). 
 
Figure 3. The impact of mutation on Reptin quaternary structure and specific 
activity. (A). Wt-Reptin, ReptinY340A, and ReptinD299N were incubated with 1mM 
ADP or without ligand and loaded onto a superose-12 gel filtration column (25 ml). 
Fractions of samples eluting from the column were absorbed onto ELISA wells. Anti-
Reptin and HRP-conjugated secondary antibodies were used to measure the extent of 
Reptin elution and binding (in RLU, chemiluminescence).  The arrows highlight the 
elution of molecular mass markers in kDa (440, Ferritin; 158, Aldolase; 43, 
Ovalbumin; 13, RNase A) in parallel processed in the absence of ADP. (B). Wild-
type Reptin and the indicated mutants were analyzed in AGR2 protein binding assays. 
AGR2 (1 g) was pre-coated onto ELISA wells. Reptin was titrated, and anti-Reptin 
and HRP-conjugated secondary antibodies were used to measure the extent of Reptin 
binding (in RLU, chemiluminescence). The diagram on the right interprets the data in 
the ELISA; mutations that drive Reptin into the monomeric state (Y340A) have a 
higher specific activity for AGR2, whilst mutations that stabilize Reptin in its 
oligomeric state (D299N) have a lower specific activity for AGR2 protein.  These 
data are consistent with the attenuation of wild-type Reptin binding to AGR2 protein 
in the presence of oligomerization-promoting ligands, Liddean or ADP (Figure 2).  
 
Figure 4.  A model describing the specific activity of Reptin as a function of its 
oligomeric state.  Reptin is presented as existing in distinct dynamic oligomeric 
states. Mutations or ligands can impact on this flux. The reason for developing a 
staged model is, firstly; there is one stable inter-subunit protein-protein interface that 
can be detected as suppressed by HDX-MS in Reptin in the presence of ATP 
(Supplementary Figure 5C and Figure 6A).  The wild-type Reptin and Y340A mutant 
form of Reptin exhibit similar suppression of deuteration at this inter-subunit protein-
protein (Figure 6A and 6B). These data suggest that the Y340A mutation has little 
impact on oligomer assembly at this site. By contrast, the Y340A mutation can 
attenuate full oligomerization at the ‘rim’ (Figure 3B and Figure 6B).  By contrast to 
the Y340A mutation that attenuates oligomer formation, the D299N mutation 
stabilizes the hexameric state in the absence of ligand (Figure 3C). The stabilization 
effect of the D299N mutation is rationalized in Figures 7-9. In contrast to mutations, 
oligomerization (hexamerization) can be stimulated by ligands such as ATP, ADP, or 
Liddean. Oligomerization stimulation of Reptin can increase or decrease its binding to 
client proteins (Figure 2). This is similar to a study on the assembly of Reptin and 
Pontin by Histone-3; where proteins that bind to the Reptin-Pontin system depend on 
the monomer to oligomer status of the two proteins [43]. 
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Figure 5. Hydrogen-Deuterium exchange mass spectrometry of Reptin in 
differing conformational states.  (A)-wild-type Reptin; (B) Y340A mutant form of 
Reptin; (C) wild-type Reptin with Pontin.  Reptin in all three conformational states 
(apo) was preincubated with or without ligand (ATP) and subjected to deuteration and 
pepsinization. The reaction products were subjected to mass spectrometry as indicated 
in the Experimental Procedures. The graphs highlight the change in the number of 
deuterons as a function of ligand from each isoform (See Supplementary Table 4). In 
addition, the average deuteration (%) of peptic peptides, as a function of primary 
amino acid sequence, of ligand-bound and ligand-free Reptin at the 300 second time 
point calculated as described [37] is summarized in Supplementary Figure 6.  
 
Figure 6.  Localization of deuteration flux superimposed on the three-
dimensional structure of Reptin. (A and B; wild-type Reptin and the Y340A mutant 
form of Reptin, respectively). The crystal structures of the Reptin containing one or 
two subunits were extracted from the hexamer crystallized as PDB code 3UK6 and 
the image contains regions highlighted by colors according to changes in deuteration. 
Red regions indicate areas of decreased deuterium exchange larger than 5% in the 
presence of ATP and blue regions indicate areas of increased exchange larger than 
5%, whilst green indicates no significant change and grey indicates regions with no 
peptic peptides detected by HDX-MS. (A) The Tyrosine finger (Y340) is indicated by 
an arrow. (B) The Tyrosine finger (Y340) mutated to alanine is indicted by an arrow. 
(C). Crystal structures of the monomeric Reptin and the Reptin-Pontin complex (PDB 
code 2XSZ) with regions highlighted by colors according to changes in deuteration. 
Red regions indicate areas of decreased exchange larger than 5% in the presence of 
ATP, while green indicates no significant change and grey indicates regions with no 
peptides detected by HDX-MS. The Tyrosine finger (Y340) is indicated by arrow. 
The Pontin is colored light pink. The image was created in PyMOL [23].  
 
Figure 7. Bimodal isotopic envelopes. Bimodal isotopic patterns were detected in 
several peptides. Shown are mass spectra of the peptide containing AAs 355-371. 
Spectra are shown for all three samples (Reptin wt, Reptin Y340A, and Reptin-
Pontin) and for these conditions: undeuterated, sample without ligand and sample 
with 1 mM ATP. Clear bimodal patterns were detected in Reptin wt after incubation 
with ATP and in Reptin-Pontin regardless of ATP. On the other hand, Reptin Y340A 
did not show clear bimodal distributions in any peptides. This is consistent with the 
data showing that mutation of tyrosine 340 alters Reptin oligomerization. All these 
findings support our interpretation that bimodal patterns are caused by presence of 
monomeric/oligomeric state of Reptin rather than EX1 kinetics. 
 
 
Figure 8. MD simulation guided modeling of Reptin oligomerization.  A 
snapshot is depicted from the MD simulations of (A). wild-type Reptin, (B). the 
Y340A mutant form of Reptin and (C). the D299N mutant form of Reptin, as 
hexamers.  Although the Y340A mutant form of reptin may not exist as a 
hexamer, the structural changes during the MD simulations, which were initiated 
from the hexameric wild type structure, show that the mutation results in loss of 
key stabilizing interactions, which would likely result in the dissociation of the 
hexamer (this dissociation would require very long simulation times) . Each 
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monomer unit is colored differently with the Tyrosine finger (Y340) highlighted 
in blue color. The data can be visualized in Supplementary movies 1-3. 
 
Figure 9. Evaluation of the D299N and Y340A forms of Reptin. (A). Distribution 
of buried surface area (BSA) of the inter-subunit protein-protein interface calculated 
from the conformations sampled during the MD simulations of wildtype and mutant 
Reptin hexamers in their apo and ADP bound states. The BSA was calculated by 
subtracting the solvent accessible surface area (SASA) of the inter-subunit protein-
protein interface from the sum of the SASA of each monomer. (B). MD snapshot of 
the Reptin hexamer showing water mediated interactions between two monomers. 
Residues (N299 from monomer A and D349 from monomer B) involved in water 
mediated interactions are highlighted in sticks, the water molecule is shown as a red 
sphere and water-mediated hydrogen bond interactions are shown as dashed lines. 
(C). Snapshot from the MD simulations highlighting the tight packing between the 
two monomers (coloured green and red) in the case of wild-type Reptin and (D). loss 
in packing interactions due to the Y340A mutation. Reptin is depicted as surface, and 
Y340 and A340 are highlighted in blue color.  
Supplementary Figure 1. Peptide map. Peptide coverage of Reptin used for 
HDX analysis 
 
Supplementary Figure 2. Butterfly plots showing the effect of ATP on overall 
Reptin wt deuteration changes 
 
Supplementary Figure 3. Butterfly plots showing the effect of ATP on overall 
Reptin Y340A deuteration changes 
 
Supplementary Figure 4. Butterfly plots showing the effect of ATP on overall 
Reptin (in Reptin-Pontin complex) deuteration changes 
 
Supplementary Figure 5A-C. Localization of deuteration flux superimposed on 
the three-dimensional structure of Reptin.    The crystal structures of the Reptin 
monomer was extracted from the hexamer crystallized as PDB code 3UK6 and the 
image contains regions highlighted by colors according to changes in deuteration. The 
green highlights the overall shape of the protein and the white or blue highlights the 
specific changes that occur at different functional motifs in Reptin (as written in A, B, 
or C and referred from Figure 6 in the text of the results section). The image was 
created in PyMOL [23].  
 
Supplementary Figure 6. Hydrogen-Deuterium exchange mass 
spectrometry of Reptin in differing conformational states.  (A)-wild-type 
Reptin; (B) Y340A mutant form of Reptin; (C) wild-type Reptin with Pontin.  Reptin 
in all three conformational states (A-C) was preincubated with or without ligand 
(ATP) and subjected to deuteration and pepsinization. The reaction products 
were subjected to mass spectrometry as indicated in the Experimental 
Procedures. The graphs highlight the average deuteration (%) of peptic peptides, 
as a function of primary amino acid sequence, of ligand-bound and ligand-free 
Reptin at the 300 second time point calculated as described [37]. Ligand-free 
Reptin in all three conformational states is shown in blue and Reptin in all three 
conformational states but pre-incubated with 1 mM ATP is shown in red.  
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Supplementary Table 1. Results of HDX analysis of Reptin WT vs Reptin ATP. 
List of peptides with deuteration levels 
 
Supplementary Table 2. Results of HDX analysis of Reptin Y340A vs Reptin 
Y340A with ATP. List of peptides with deuteration levels 
 
Supplementary Table 3. Results of HDX analysis of Reptin with Pontin vs 
Reptin with Pontin and ATP. List of peptides with deuteration levels 
 
Supplementary Table 4. HDX analysis that summarizes changes in the 
number of deuterons in a given peptide.  The data include peptides from; 
Reptin, Reptin Y340A, and the Reptin-Pontin complex. 
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Highlights 
 Reptin is an oligomeric and oncogenic member of the AAA+ protein 
superfamily 
 A linear peptide motif screen identified a dominant oligomer assembly motif 
 Mutation of an inter-subunit bridge at Y340 attenuated oligomerization 
 HDX mass spectrometry was used to map dynamics in the Y340A mutant 
assembly 
 MD simulations rationalized monomer-oligomer equilibrium in Y340A and 
D299N mutants 
 These data identify “hot-spot’ sites that regulate assembly of the Reptin 
oligomer 
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